Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Qbic Fund is an inter-university venture capital fund based in St-Denijs-Westrem, Belgium, founded in 2012. The fund has an AUM of €190 million and supports spin-offs and start-ups that valorize research from its knowledge partners, which include various Belgian universities and research institutes. It currently manages three funds, with ongoing investments from Qbic III.
This sector-agnostic fund invests in seed and early-stage companies, typically participating in their first external investment round. Qbic Fund primarily targets knowledge partner spin-offs and start-ups linked to its academic collaborators, aiming to support technological innovations and R&D collaborations.
Notable portfolio companies include AILOS, redefining actuation for next-generation robotics; Innocens, developing AI-powered alerts for patient deterioration; and Spica Therapeutics, pioneering macrophage-subset targeted therapies. Other companies include eyeo, Rainbow Crops, Pleevi, Tanai Therapeutics, Flindr, VoxelSensors, and Animab.
To pitch Qbic Fund, email info@qbic.be with your deck.
Yes, Qbic Fund typically leads the first external investment round for the companies it supports.
Qbic Fund continues to support its portfolio companies throughout their growth, which may include follow-on investments as needed.
Qbic Fund currently manages an AUM of €190 million across its three funds.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.